TABLE 1.
Table containing statistics and information on the 16 patients enrolled in the CROFT study
| (A) Variable | Summary statistics | Patient population N = 16 |
|---|---|---|
| Age (years) | Mean ± SD; Median (min‐max) | 64.8 ± 13.1; 67(33–83) |
| Male sex | N (%) | 12 (75%) |
| Body mass index (kg/m2) | Mean ± SD; Median (min‐max) | 27.8 ± 5.6; 26.2 (19.6–39.5) |
| Extracardiac arteriopathy | N (%) | 1 (6%) |
| Sinus rhythm | N (%) | 15 (88%) |
| Urgent indication | N (%) | 5 (29%) |
| Aetiology: | ||
| Mitral/Aortic valve disease | N (%) | 9 (53%) |
| Coronary artery disease | N (%) | 5 (29%) |
| Valvular and ascending aorta | N (%) | 2 (12%) |
| Valvular and coronary disease | N (%) | 1 (6%) |
| Family history of cardiovascular disease | N (%) | 6 (35%) |
| Hypertension | N (%) | 12 (71%) |
| Diabetes mellitus | N (%) | 4 (23%) |
| Smoker | N (%) | 3 (18%) |
| COPD | N (%) | 1 (6%) |
| Renal failure | N (%) | 2 (12%) |
| Cerebrovascular accident | N (%) | 2 (12%) |
| Leukocyte | Mean ± SD; Median (min‐max) | 6.3 × 109 ± 2; 6.3 × 109 (3.1–10.4) |
| Creatinine (mg/dl) | Mean ± SD; Median (min‐max) | 1.01 ± 0.33; 0.89 (0.65–1.77) |
| C‐Reactive protein (mg/dl) | Mean ± SD; Median (min‐max) | 0.3 ± 0.2; 0.3 (0–0.7) |
| Hemoglobin (g/dl) | Mean ± SD; Median (min‐max) | 13.4 ± 1.9; 13.3 (10.5–16.5) |
| NYHA III ‐ IV | N (%) | 2 (12%) |
| Ejection fraction (%) | Mean ± SD; Median (min‐max) | 56.8 ± 10.4; 60 (35–75) |
| euro SCORE I | Mean ± SD; Median (min‐max) | 4.8 ± 3.5; 5 (0–11) |
| euro SCORE II | Mean ± SD; Median (min‐max) | 6.2 ± 7.1; 3.98 (0.88–24.9) |
| Logistic EuroSCORE | Mean ± SD; Median (min‐max) | 3.1 ± 3.9; 1.98 (0.56–15.81) |